Volume 98, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



The differential diagnosis of dengue virus (DENV) and yellow fever virus (YFV) infections in endemic areas is complicated by nonspecific early clinical manifestations. In this study, we describe an internally controlled, multiplex real-time reverse transcription polymerase chain reaction (rRT-PCR) for the detection of DENV and YFV. The DENV–YFV assay demonstrated specific detection and had a dynamic range of 2.0–8.0 log copies/μL of eluate for each DENV serotype and YFV. Clinical performance was similar to a published pan-DENV assay: 48/48 acute-phase samples from dengue cases were detected in both assays. For YFV detection, mock samples were prepared with nine geographically diverse YFV isolates over a range of concentrations. The DENV–YFV assay detected 62/65 replicates, whereas 54/65 were detected using a reference YFV rRT-PCR. Given the reemergence of DENV and YFV in areas around the world, the DENV–YFV assay should be a useful tool to narrow the differential diagnosis and provide early case detection.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Monath TP, Vasconcelos PF, 2015. Yellow fever. J Clin Virol 64: 160173.
    [Google Scholar]
  2. Dexheimer Paploski IA et al., 2017. Epizootic outbreak of yellow fever virus and risk for human disease in Salvador, Brazil. Ann Intern Med 168: 301302.
    [Google Scholar]
  3. World Health Organization, 2017. Yellow Fever Outbreak Angola, Democratic Republic of the Congo and Uganda 2016–2017. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/emergencies/yellow-fever/en/. Accessed January 8, 2018.
  4. Domingo C, Patel P, Yillah J, Weidmann M, Méndez JA, Nakouné ER, Niedrig M, 2012. Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. J Clin Microbiol 50: 40544060.
    [Google Scholar]
  5. World Health Organization, 2016. Yellow Fever. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/mediacentre/factsheets/fs100/en/. Accessed April 4, 2017.
  6. Domingo C, Escadafal C, Rumer L, Mendez JA, Garcia P, Sall AA, Teichmann A, Donoso-Mantke O, Niedrig M, 2012. First international external quality assessment study on molecular and serological methods for yellow fever diagnosis. PLoS One 7: e36291.
    [Google Scholar]
  7. Pan American Health Organization, 2017. Laboratory Diagnosis of Yellow Fever Virus Infection. Washington, DC: Pan American Health Organization.
  8. World Health Organization, 2009. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva, Switzerland: WHO Press.
  9. Bae HG, Nitsche A, Teichmann A, Biel SS, Niedrig M, 2003. Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J Virol Methods 110: 185191.
    [Google Scholar]
  10. Nunes MR, Palacios G, Nunes KN, Casseb SM, Martins LC, Quaresma JA, Savji N, Lipkin WI, Vasconcelos PF, 2011. Evaluation of two molecular methods for the detection of yellow fever virus genome. J Virol Methods 174: 2934.
    [Google Scholar]
  11. Reusken CBEM, Knoester M, GeurtsvanKessel C, Koopmans M, Knapen DG, Bierman WFW, Pas S, 2017. Urine as sample type for molecular diagnosis of natural yellow fever virus infections. J Clin Microbiol 55: 32943296.
    [Google Scholar]
  12. Waggoner JJ et al., 2013. Development of an internally controlled real-time reverse transcriptase PCR assay for pan-dengue virus detection and comparison of four molecular dengue virus detection assays. J Clin Microbiol 51: 21722181.
    [Google Scholar]
  13. Waggoner JJ et al., 2014. Multiplex nucleic acid amplification test for diagnosis of dengue fever, malaria, and leptospirosis. J Clin Microbiol 52: 20112018.
    [Google Scholar]
  14. Waggoner JJ, Gresh L, Mohamed-Hadley A, Ballesteros G, Davila MJ, Tellez Y, Sahoo MK, Balmaseda A, Harris E, Pinsky BA, 2016. Single-reaction multiplex reverse transcription PCR for detection of zika, chikungunya, and dengue viruses. Emerg Infect Dis 22: 12951297.
    [Google Scholar]
  15. Burd EM, 2010. Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev 23: 550576.
    [Google Scholar]
  16. Kuan G, Gordon A, Aviles W, Ortega O, Hammond SN, Elizondo D, Nunez A, Coloma J, Balmaseda A, Harris E, 2009. The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol 170: 120129.
    [Google Scholar]
  17. Waggoner JJ et al., 2013. Comparison of the FDA-approved CDC DENV-1–4 real-time reverse transcription-PCR with a laboratory-developed assay for dengue virus detection and serotyping. J Clin Microbiol 51: 34183420.
    [Google Scholar]
  18. Colebunders R et al., 2002. A Belgian traveler who acquired yellow fever in the Gambia. Clin Infect Dis 35: e113e116.
    [Google Scholar]
  19. Shearer FM et al., 2017. Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis. Lancet Infect Dis 17: 12091217.
    [Google Scholar]
  20. Pan American Health Organization/World Health Organization, 2017. Epidemiological Update: Yellow Fever. Washington, DC: PAHO/WHO.

Data & Media loading...

Supplemental Text and Table

  • Received : 11 Jan 2018
  • Accepted : 16 Feb 2018
  • Published online : 02 Apr 2018
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error